Global Companion Diagnostic Technologies Market Trends, Company Profiles, Demand, Insights, Analysis, Forecast, 2013 - 2020

1
Global Companion Diagnostic Technologies Market
(Indication and Geography) - Trends, Company
Profiles, Demand, Insights, Analysis, Research,
Report, and Forecast, 2013 - 2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
2
Report Overview
Companion diagnostics are in-vitro diagnostics
that provide information about therapeutic
responses of patients for a specific treatment.
Companion diagnostics market is still nascent,
and it is projected to reach 3.5 billion by 2020
from a base value of 1.1 billion in 2013,
growing at a CAGR of 20 during 2014 to 2020. The
global companion diagnostic market is segmented
based on indication, technology and geography
(North America, Europe, Asia Pacific and
LAMEA). Geographically, LAMEA is the fastest
growing region. The key drivers for this market
are the increase in the discovery of biomarkers
and co-development of drug and corresponding
diagnostic. However, cost associated with
developing drugs could impede the growth of this
market. Read the Complete Report
_at_ http//www.researchbeam.com/companion-diagnostic
-technologies-market
3
Report Overview
Opportunities for this market lie in developing
companion diagnostics for various central nervous
system conditions and hereditary
conditions. Companion Diagnostics Indication
Market Analysis Companion diagnostics is
segmented on the basis of its use for indications
such as oncology, cardiovascular conditions,
central nervous system indications, inflammation
and virology. Oncology is the highest revenue
generating segment, as majority of the companion
diagnostics have been developed for detection of
various cancer biomarkers. The key driver for
this market is an increase in research and
development of targeted drugs, which require a
corresponding companion diagnostic.
4
Report Overview
Companion Diagnostics Technology Market
Analysis Companion diagnostics technology market
is segmented into Immunohistochemistry and
Molecular diagnostics. Molecular diagnostics
would be the fastest growing and highest revenue
generator, mainly due to the use of techniques
such as real time PCR, In Situ Hybridization and
next generation sequencing. Companion
Diagnostics Geography Market Analysis Companion
Diagnostics market has been segmented
geographically into North America, Europe, Asia
Pacific and LAMEA. North America has the major
market share of 43.97 followed by Europe, which
accounted for about 38 of the overall CD market
in 2013. North America and Europe together
accounted for over 82 in the global CD market in
2013 and they would continue to be the major
markets through 2020.
5
Key Benefits

• In-depth analysis of the companion diagnostic
  market by technology and indications give a clear
  idea of the scope of this market
• Analysis of the market by geography would help in
  making region specific plans
• Estimations for period of 2013 to 2020 have been
  given, taking into consideration the current
  market scenario and future trends, which would
  give a clearer picture of the potential of the
  market
• Porters five force model and SWOT analysis would
  help in a deeper understanding of the market and
  help in making strategic decisions

6
Market By Technology

• Immunohistochemistry
• Molecular diagnostics
• In situ Hybridization
• FISH
• CISH
• Feel free to enquire about an report _at_
  http//www.researchbeam.com/companion-diagnostic-t
  echnologies-market/enquire-about-report

7
Table of Content
CHAPTER 1. INTRODUCTION 1.1 Report
description 1.2 Key market segments 1.3 Research
methodology CHAPTER 2. EXECUTIVE
SUMMARY CHAPTER 3. MARKET OVERVIEW 3.1 Market
Definition and Scope 3.2 Companion Diagnostics
for Metabolic Diseases 3.3 Novel trends and
technologies in companion diagnostics assay
development 3.4 Companion diagnostics as a new
trend in personalized medicine
8
(No Transcript)